IBS

CinCor’s ‘hub-and-spoke’ parent nabs new funding to build its next biotechs
BioPharma Dive
Thu, 05/30/24 - 11:10 am
CinRx Pharma
funding
obesity
IBS
gastroparesis
Tryp to initiate psilocybin-assisted psychotherapy trial to treat IBS
Clinical Trials Arena
Fri, 07/14/23 - 10:01 am
Tryp Therapeutics
clinical trials
IBS
psilocybin
Why Shares of Bausch Health Soared Wednesday
Motley Fool
Wed, 05/17/23 - 10:42 pm
Bausch Health
IBS
Xifaxan
patents
legal
Trio of biotechs raise funds to make enzymes and develop drugs for IBS and other autoimmune diseases
Endpoints
Fri, 07/8/22 - 10:56 am
Hulli Bio
funding
IBS
Precision Autoimmune Therapeutics
autoimmune disease
Zhiyi Biotech
Arena's pain drug fails phase 2b, prompting review of 'strategic options'
Fierce Biotech
Wed, 03/3/21 - 10:50 am
Arena Pharmaceuticals
clinical trials
olorinab
IBS
Arena Pharmaceuticals’ Selective CB2 Receptor Activator Drug Candidate Fights Pain in Irritable Bowel Syndrome
Xtalks
Wed, 06/5/19 - 10:09 am
IBS
Arena Pharmaceuticals
cannabinoid type 2 receptors
4D pharma begins patient enrollment in Blautix IBS phase II study
Pharmaceutical Business Review
Fri, 11/9/18 - 11:47 am
4D Pharma
IBS
clinical trials
Blautix
Ironwood steps up to challenge Valeant with Allergan's IBS med Viberzi
Fierce Pharma Marketing
Wed, 08/12/15 - 09:09 am
Valeant Pharmaceuticals
Ironwood
Allergan
IBS
Viberzi
Valeant plots big DTC push for Xifaxan while rival Actavis drug waits on DEA
Fierce Pharma Marketing
Mon, 06/1/15 - 12:18 pm
Valeant Pharmaceuticals
DTC
Xifaxan
Actavis
IBS
Viberzi
FDA approves Actavis, Valeant drugs for irritable bowel syndrome
Yahoo/Reuters
Wed, 05/27/15 - 08:27 pm
FDA
Actavis
Valeant Pharmaceuticals
IBS
irritable bowel syndrome
Xifaxan
Viberzi
AstraZeneca partner Ardelyx plunges after citing safety issue for lead drug
Fierce Biotech
Mon, 02/2/15 - 03:21 pm
AstraZeneca
Ardelyx
tenapanor
IBS
Ardelyx irritable bowel syndrome drug succeeds in mid-stage trial
Reuters
Wed, 10/1/14 - 08:19 am
Ardelyx
IBS
irritable bowel syndrome
tenapanor
AstraZeneca Pharma India
New biotherapeutics drug for Crohn's to enter trials
Pharmaphorum
Wed, 09/3/14 - 08:17 am
Crohn's Disease
IBS
Blautix
Thetanix
4D Pharma
Furiex irritable bowel syndrome drug succeeds in large trials
Yahoo/Reuters
Tue, 02/4/14 - 07:44 am
IBS
Furiex Pharmaceuticals
eluxadoline
IBS-d
Ironwood's Bowel Drug Sales Disappoint
TheStreet.com
Tue, 04/23/13 - 10:47 am
Ironwood
Linzess
Forest Labs
irritable bowel syndrome
IBS
European Medicines Agency has recommendations for Novartis, Pfizer, Bristol-Myers Squibb and others
Pharma Times, UK
Mon, 09/24/12 - 11:07 am
Pfizer
Bristol-Myers Squibb
Eliquis
stroke
IBS
Almirall
Novartis
Europe
Sucampo presents data for AMITIZA for treatment of IBS-C
Yahoo/Fly on the Wall
Mon, 05/21/12 - 12:52 pm
Sucampo
Amitiza
IBS
IBS-C
The FDA's Drug Approval Agenda for Next Week
Seeking Alpha
Thu, 06/16/11 - 11:42 am
FDA
Xifaxan
Salix
IBS
Remoxy
Durect Corporation
Pain Therapeutics
Pfizer
painkillers
FDA gives fast-track status to Tioga irritable bowel drug
San Diego Union Tribune, CA
Thu, 06/2/11 - 10:47 am
irritable bowel syndrome
FDA
IBS
Tioga
fast track
Salix's IBS drug fails to get FDA nod
Reuters
Tue, 03/8/11 - 11:48 am
FDA
Salix
IBS
irritable bowel syndrome
Xifaxan

Pages